T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) Meeting Abstract
| Authors: | McCoon, P.; Lee, Y. S.; Kelley, R. K.; Guthrie, V. B.; Wu, S.; Bien, S. A.; Negro, A.; He, P.; Kurland, J.; Barrett, J. C.; Pilataxi, F.; Ching, S.; Abou-Alfa, G. K. |
| Abstract Title: | T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602187 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4087 -- Source: Wos |
